Desk›Chemicals› Camlin Fine Sciences Ltd
Camlin Fine Sciences Ltd
BSE 532834 · NSE CAMLINFINE · ISIN INE052I01032 · Group B · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹103.10
-3.55%
BSE close, 28 August 2026
₹1,980.52 cr
19.2 cr shares · Micro cap
₹930.72 cr
as published
-57.3× · 3.15×
EPS ₹-1.80 · BV ₹32.73
837.92 / -32.97
₹ cr, as filed
16
5 selected · 31%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -55.9% |
|---|---|
| Against 52-week low | +7.1% |
| Day change | -3.55% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-1.80 |
|---|---|
| Price / earnings | -57.28× |
| Price / book | 3.15× |
| Book value — derived, price ÷ P/B | ₹32.73 |
| Return on equity | -5.49% |
| Operating margin | 3.70% |
| Net margin | -5.53% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -5.50%
- ROE as published
- -5.49%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 222.49 | -12.31 | -0.64 | 3.70% | -5.53% |
| Mar-26 · Q | 183.52 | -5.65 | -0.29 | 10.19% | -3.08% |
| FY25-26 | 837.92 | -32.97 | -1.74 | 7.94% | -3.93% |
Quarter on quarter
- Revenue, quarter on quarter
- +21.2%
- Net profit, quarter on quarter
- -117.9%
- Operating margin, quarter on quarter
- -649 bps
Disclosure profile 16 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 5 |
| Procedural | |
| AGM / EGM | 2 |
| Analyst / Investor Meet | 2 |
| Newspaper Publication | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Postal Ballot | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 11 |
| Total | 16 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
16 filings · 5 selected · busiest 2026-08-11
Filing rhythm · the twelve most recent
2026-08-112026-10-06
SelectedProcedural
Filings
16 in the window · 7 earlier on record
-
6 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
24 September 2026 ·
Closure of Trading Window
Closure of trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
16 September 2026 ·
Newspaper Publication
Newspaper Publication - Dispatch of Notice of Postal Ballot
Company Update / Newspaper Publication View filing →
-
15 September 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
AGM/EGM / Postal Ballot View filing →
-
9 September 2026 ·
Change in Management
Appointment of Additional Non-executive Independent Director of the Company.
Company Update / Change in Management View filing →
-
17 August 2026 ·
Earnings Call Transcript
Transcript of the Earnings Call Q1FY27
Company Update / Earnings Call Transcript View filing →
-
12 August 2026 ·
Newspaper Publication
Newspaper Publication - Unaudited Financial Results for the quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Analyst / Investor Meet - Outcome
Investor Call Recording Q1 FY27
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026 ·
Investor Presentation
Investor Presentation Q1 FY27
Company Update / Investor Presentation View filing →
-
11 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Dated August 11, 2026
Outcome of Board Meeting dated August 11, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
11 August 2026 ·
Un-Audited Financial Results For The Quarter Ended June 30, 2026
Un-audited Financial Results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizers Report with Voting Results of 33rd AGM
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 33rd AGM
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Analyst / Investor Meet - Intimation
Schedule of Investor Meet - Q1FY27 Earnings Call
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter Ended June 30, 2026.
Camlin Fine Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Board Meeting / Board Meeting View filing →
-
28 July 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 28, 2026 for Ashish Subhash Dandekar
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
RSS feed for Camlin Fine Sciences Ltd · the 50 most recent filings